Lv8
8535 积分 2024-04-30 加入
The evolving landscape of obesity pharmacotherapy
7小时前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
1天前
已完结
CAR T-cell therapy “Living drugs” in systemic lupus erythematosus
3天前
已完结
Systemic lupus erythematosus: Phase 3 clinical trials to watch
6天前
已完结
Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study
6天前
已关闭
Germinal-centre and extrafollicular B cell pathways in systemic lupus erythematosus
6天前
已完结
Systemic lupus erythematosus: Phase 3 clinical trials to watch
7天前
已关闭
Long-term clinical outcomes and safety of rituximab in refractory neuropsychiatric systemic lupus erythematosus: a real-world single-center study
7天前
已完结
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
7天前
已完结
皖公网安备34019202002308
